Jain Vivek's Form 4 filing
Icu Medical Inc (ICUI) · filed Jun 15, 2023
- Accession no.
- 0001410442-23-000004
- Filed
- Jun 15, 2023
- Trade date
- Jun 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 20 non-derivative transactions and 10 derivative transactions. Open-market sales total $5.66M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jain VivekCIK 0001410442 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +6,712 | $58.79 | +$394,598.48 | 30,389 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −6,712 | $185.73F2 | −$1,246,619.76 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +3,637 | $58.79 | +$213,819.23 | 27,314 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −3,637 | $186.50F3 | −$678,300.5 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +2,781 | $58.79 | +$163,494.99 | 26,458 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −2,781 | $187.43F4 | −$521,242.83 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +8,163 | $58.79 | +$479,902.77 | 31,840 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −8,163 | $188.52F5 | −$1,538,888.76 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +785 | $58.79 | +$46,150.15 | 24,462 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −785 | $189.32F6 | −$148,616.2 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +1,699 | $58.79 | +$99,884.21 | 25,376 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −1,699 | $190.48F7 | −$323,625.52 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +1,601 | $58.79 | +$94,122.79 | 25,278 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −1,601 | $192.06F8 | −$307,488.06 | 23,677 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +2,104 | $58.79 | +$123,694.16 | 25,781 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +2,418 | $58.79 | +$142,154.22 | 28,199 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −2,418 | $194.02F9 | −$469,140.36 | 25,781 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +100 | $58.79 | +$5,879 | 25,881 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −100 | $194.73F10 | −$19,473 | 25,781 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −2,104 | $193.30F11 | −$406,703.2 | 23,677 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −6,712 | $0.00 | $0 | 199,654 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −3,637 | $0.00 | $0 | 196,017 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −2,781 | $0.00 | $0 | 193,236 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −8,163 | $0.00 | $0 | 185,073 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −785 | $0.00 | $0 | 184,288 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −1,699 | $0.00 | $0 | 182,589 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −1,601 | $0.00 | $0 | 180,988 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −2,104 | $0.00 | $0 | 178,884 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −2,418 | $0.00 | $0 | 176,466 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 176,366 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.05 to $187.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.05 to $188.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.06 to $189.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.16 to $191.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.44 to $192.385, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $194.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F10
All shares sold were sold at the exact price disclosed.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.52 to $193.515, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.